Protea Licenses Cardiovascular Biomarker Tech from Hopkins

The company plans to develop a rapid test to help doctors make critical treatment decisions in myocardial ischemia cases.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.